Glucocerebrosidase gene therapy in animal models of Parkinson Disease
Parkinson´s Disease (PD) is the first most common movement disorder and second most common neurodegenerative disease that affects 1.5% of the global population above 65 years old. Although the incidence of PD varies depending on genetic, race/ethnicity and environmental factors, advanced age has bee...
| 主要な著者: | , , |
|---|---|
| フォーマット: | info:eu-repo/semantics/doctoralThesis |
| 言語: | eng |
| 出版事項: |
Universidad de Navarra
2021
|
| 主題: | |
| オンライン･アクセス: | https://hdl.handle.net/10171/61068 |
| 要約: | Parkinson´s Disease (PD) is the first most common movement disorder and second most common neurodegenerative disease that affects 1.5% of the global population above 65 years old. Although the incidence of PD varies depending on genetic, race/ethnicity and environmental factors, advanced age has been appointed as the main risk factor for PD. |
|---|